Genome scientist Craig Venter in deal to make humanized pig organs | CHICAGO (Reuters) - Genome pioneer J. Craig Venter is teaming up with a unit of United Therapeutics Corp to develop pig lungs that have been genetically altered to be compatible with humans, a feat that, if successful, could address the urgent need for transplant organs for people with end-stage lung disease. | | | | Astra gets lift in Pfizer fight as U.S. okays heart pill | LONDON (Reuters) - AstraZeneca Plc has won U.S. approval for Epanova, a new pill for heart disease, providing a welcome - but relatively minor - piece of good news as it fights a $106 billion takeover approach from Pfizer Inc. | | | | Deaths fell after Massachusetts healthcare overhaul: study | NEW YORK (Reuters Health) - When Massachusetts blazed the trail of healthcare reform in 2006 by expanding coverage for the poor and requiring all residents to have health insurance, it may have done more than serve as a model for nationwide reform: it also seemed to save lives, according to a study released on Monday. | | | | Coke to remove controversial chemical from Fanta, other drinks | NEW YORK (Reuters) - The Coca-Cola Company said on Monday it will remove a controversial flavoring stabilizer from some of its drinks, following rival PepsiCo Inc's announcement earlier this year that it would drop the same ingredient from its drinks. | | | All workers test negative for MERS at Indiana hospital-official | MUNSTER Ind. (Reuters) - All workers at the Indiana hospital where the first U.S. case of the often deadly Middle East Respiratory Syndrome was confirmed last week have tested negative for the virus, officials at Community Hospital in Munster, Indiana, said on Monday. | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment